Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-assisted Psychotherapy for Depression in Abstinent Opioid Users
NCT05193318Phase 2Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), sponsored by Medical University of South Carolina. Started Jan 2022; status: terminated.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05193318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05193318.